Status:
COMPLETED
Endobronchial Ultrasound vs Mediastinoscopy in NSCLC
Lead Sponsor:
University Health Network, Toronto
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Proper staging of Lung cancer is of paramount concern when determining a treatment regime. Currently the assessment of surgical candidacy is performed with the staging process, mainly the mediastinosc...
Eligibility Criteria
Inclusion
- A) Age 18 years or older B) Patients with confirmed or suspected non-small cell lung cancer who require a mediastinoscopy as part of their staging investigations of the mediastinum to determine suitability for lung cancer resection will be considered for the trial.
- C) Patients with undiagnosed enlarged lymph nodes in the mediastinum suspicious for lung cancer in which a tissue diagnosis is required.
Exclusion
- A) Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy or a mediastinoscopy or who are not suitable for definitive surgical resection by thoracotomy will be excluded.
- B) Patients who have verified stage IV disease or who are not appropriate for lung cancer resection by virtue of direct invasion of mediastinal structures or large parts of the chest wall.
- C) Known small cell lung cancer. D) Patients where there is a high clinical suspicion of lymphoma. E) Inability to give informed consent.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00372203
Start Date
July 1 2006
End Date
March 1 2010
Last Update
May 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network (Toronto General Hospital)
Toronto, Ontario, Canada, M5G 2C4